InvestorsHub Logo
Followers 68
Posts 5584
Boards Moderated 0
Alias Born 01/13/2012

Re: Jimzin post# 27650

Monday, 12/24/2012 12:34:07 PM

Monday, December 24, 2012 12:34:07 PM

Post# of 331192
Hey I'm Rich:
To expand on Jimzin's rationale,
If BIEL was to accept FDA designations of Class III on all its' products and pay Sales Reps generous commissions on sales generated by Rx's written by doctors, would they not be further ahead by this proactive approach while the FDA sorts out Class II versus Class III approvals for such safe devices?

At the moment there are no FDA approvals for anything BIEL except the Recovery Rx eye indication, so there is nothing but inertia in the US. We are the hub of pharma comedy - State of Maryland issues a financial grant so BIEL can develop sales in other countries, while FDA ponders such for 2 or 3 years? Wait....what?

Speaking of other countries, what are sales in Canada, web-based and otherwise, where the Health Canada approvals for OTC sales are in place?

I am totally convinced that Class III in the U.S. and developing Class II OTC sales in Canada and the UK for the next 12 months satisies all 3 categories - puts cash flow and value into the company through increased share price - makes every shareholder including the Whelans winners - and leads to better lives.
Season's Greetings and a prosperous and healthy 13 everyone - GO BIEL! Drug Free, Side-effect free pain relief! Go FDA!